SEC FORM
4
SEC Form 4
| FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
|
| OMB APPROVAL |
| OMB Number: |
3235-0287 |
| Estimated average burden |
| hours per response: |
0.5 |
|
|
 |
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b). |
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
QUESTCOR PHARMACEUTICALS INC
[ QCOR ]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
Director |
X |
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
3. Date of Earliest Transaction
(Month/Day/Year)
07/16/2008
|
4. If Amendment, Date of Original Filed
(Month/Day/Year)
|
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Form filed by One Reporting Person |
| X |
Form filed by More than One Reporting Person |
|
| Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
|---|
| 1. Title of Security (Instr.
3)
|
2. Transaction Date
(Month/Day/Year) |
2A. Deemed Execution Date, if any
(Month/Day/Year) |
3. Transaction Code (Instr.
8)
|
4. Securities Acquired (A) or Disposed Of (D) (Instr.
3, 4 and 5)
|
5.
Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr.
4)
|
7. Nature of Indirect Beneficial Ownership (Instr.
4)
|
| Code |
V |
Amount |
(A) or (D) |
Price |
| Common Stock, no par value per share |
07/16/2008 |
|
S |
|
100,000 |
D |
$4.9147
|
7,108,889 |
I |
Shares directly held by Chaumiere - Consultadoria & Servicos SDC Unipessoal L.d.A.
|
| Common Stock, no par value per share |
|
|
|
|
|
|
|
549,100 |
I |
Shares directly held by Aptafin S.p.A.
|
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
|
|---|
| 1. Title of Derivative Security (Instr.
3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Transaction Date
(Month/Day/Year) |
3A. Deemed Execution Date, if any
(Month/Day/Year) |
4. Transaction Code (Instr.
8)
|
5.
Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
3, 4 and 5)
|
6. Date Exercisable and Expiration Date
(Month/Day/Year) |
7. Title and Amount of Securities Underlying Derivative Security (Instr.
3 and 4)
|
8. Price of Derivative Security (Instr.
5)
|
9.
Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
4)
|
10. Ownership Form: Direct (D) or Indirect (I) (Instr.
4)
|
11. Nature of Indirect Beneficial Ownership (Instr.
4)
|
| Code |
V |
(A) |
(D) |
Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
1. Name and Address of Reporting Person*
(Street)
|
1. Name and Address of Reporting Person*
(Street)
|
1. Name and Address of Reporting Person*
| 77-6F AVENIDA ARRINGA EDIFICIO FORUM P. |
|
(Street)
| FUNCHAL - MADEIRA |
S1 |
9000 |
|
| Explanation of Responses: |
|
| Remarks: |
|
|
/s/ Fabio Poma, Attorney-In-Fact for Paolo Cavazza |
07/17/2008 |
|
/s/ Fabio Poma, Attorney-In-Fact for Aptafin S.p.A. |
07/17/2008 |
|
/s/ Fabio Poma, Attorney-In-Fact for Chaumiere - Consultadoria & Servicos SDC Unipessoal L.d.A. |
07/17/2008 |
|
** Signature of Reporting Person |
Date |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
| * If the form is filed by more than one reporting person,
see
Instruction
4
(b)(v). |
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure. |
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |
POWER OF ATTORNEY
The undersigned does hereby constitute and appoint each of Fabio Poma, Rocco
Nava and Nicola Wullschleger, with full power of substitution, as the true and
lawful attorney-in-fact and agent of the undersigned, and authorizes and
designates each of the foregoing attorneys-in-fact to sign on the behalf of the
undersigned, and to file filings and any amendments thereto, with the Securities
and Exchange Commission, made by or on behalf of the undersigned in respect of
(i) the beneficial ownership of equity securities of QUESTCOR PHARMACEUTICALS
INC. held by the undersigned directly, indirectly or beneficially, pursuant to
Sections 13(d), 13(g) and 16 of Securities Exchange Act of 1934, as amended (the
"Exchange Act"), and the rules and regulations thereunder and (ii) the
disposition of equity securities of QUESTCOR PHARMACEUTICALS INC. held by the
undersigned, directly, indirectly or beneficially, in accordance with Rule 144
of the Securities Act of 1933, as amended (the "Securities Act"), and the rules
and regulations thereunder, including the filing of any Form 144 pursuant to the
Securities Act. The undersigned acknowledges that the foregoing
attorneys-in-fact, in serving in such capacity at the request of the
undersigned, are not assuming any of the undersigned's responsibilities to
comply with Sections 13(d), 13(g) or 16 of the Exchange Act or Rule 144 of the
Securities Act.
This Power of Attorney shall remain in full force and effect until withdrawn by
the undersigned in a signed writing delivered to each of the foregoing
attorneys-in-fact.
IN WITNESS WHEREOF, each of the undersigned has caused this Power of Attorney
to be executed as of this 14th day of July, 2008.
APTAFIN S.p.A.
By: /s/ Maurizio Terenzi
Name: Maurizio Terenzi
Title: Amministratore Delegato
